Literature DB >> 23410258

Low vaccine effectiveness against influenza A(H3N2) virus among elderly people in Denmark in 2012/13--a rapid epidemiological and virological assessment.

K Bragstad1, Hd Emborg, T K Fischer, M Voldstedlund, S Gubbels, B Andersen, K Molbak, Tg Krause.   

Abstract

In Denmark, the 2012/13 influenza season has been dominated by influenza A(H3N2). We estimated the vaccine effectiveness (VE) of the trivalent influenza vaccine by linking national registers in a test-negative case-control study of patients tested for influenza aged ≥65 years. The adjusted VE against laboratory-confirmed influenza A and B was -11% (95% CI: -41 to 14) and 69% (95% CI: 26 to 87), respectively. Genetic characterisation of the influenza A(H3N2) viruses indicated genetic drift, with seven substitutions at key antigenic sites.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23410258

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  22 in total

Review 1.  Influenza vaccine failure: failure to protect or failure to understand?

Authors:  Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2018-06-26       Impact factor: 5.217

2.  The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012.

Authors:  Nikki Turner; Nevil Pierse; Ange Bissielo; Q Sue Huang; Michael G Baker; Marc-Alain Widdowson; Heath Kelly
Journal:  Vaccine       Date:  2014-04-24       Impact factor: 3.641

3.  Haemagglutinin mutations and glycosylation changes shaped the 2012/13 influenza A(H3N2) epidemic, Houston, Texas.

Authors:  K M Stucker; S A Schobel; R J Olsen; H L Hodges; X Lin; R A Halpin; N Fedorova; T B Stockwell; A Tovchigrechko; S R Das; D E Wentworth; J M Musser
Journal:  Euro Surveill       Date:  2015-05-07

4.  The effect of sex on responses to influenza vaccines.

Authors:  Lucy Denly
Journal:  Hum Vaccin Immunother       Date:  2020-11-12       Impact factor: 3.452

5.  The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology.

Authors:  Huiying Chua; Shuo Feng; Joseph A Lewnard; Sheena G Sullivan; Christopher C Blyth; Marc Lipsitch; Benjamin J Cowling
Journal:  Epidemiology       Date:  2020-01       Impact factor: 4.822

Review 6.  Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectiveness.

Authors:  Maryna C Eichelberger; David M Morens; Jeffery K Taubenberger
Journal:  Curr Opin Immunol       Date:  2018-04-16       Impact factor: 7.486

7.  Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany.

Authors:  Cornelius Remschmidt; Thorsten Rieck; Birte Bödeker; Ole Wichmann
Journal:  BMC Infect Dis       Date:  2015-03-20       Impact factor: 3.090

8.  Effectiveness of Trivalent Inactivated Influenza Vaccine in Children Estimated by a Test-Negative Case-Control Design Study Based on Influenza Rapid Diagnostic Test Results.

Authors:  Masayoshi Shinjoh; Norio Sugaya; Yoshio Yamaguchi; Yuka Tomidokoro; Shinichiro Sekiguchi; Keiko Mitamura; Motoko Fujino; Hiroyuki Shiro; Osamu Komiyama; Nobuhiko Taguchi; Yuji Nakata; Naoko Yoshida; Atsushi Narabayashi; Michiko Myokai; Masanori Sato; Munehiro Furuichi; Hiroaki Baba; Hisayo Fujita; Akihiro Sato; Ichiro Ookawara; Kenichiro Tsunematsu; Makoto Yoshida; Mio Kono; Fumie Tanaka; Chiharu Kawakami; Takahisa Kimiya; Takao Takahashi; Satoshi Iwata
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

9.  Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type.

Authors:  Huong Q McLean; Mark G Thompson; Maria E Sundaram; Burney A Kieke; Manjusha Gaglani; Kempapura Murthy; Pedro A Piedra; Richard K Zimmerman; Mary Patricia Nowalk; Jonathan M Raviotta; Michael L Jackson; Lisa Jackson; Suzanne E Ohmit; Joshua G Petrie; Arnold S Monto; Jennifer K Meece; Swathi N Thaker; Jessie R Clippard; Sarah M Spencer; Alicia M Fry; Edward A Belongia
Journal:  J Infect Dis       Date:  2014-11-18       Impact factor: 5.226

10.  Clinical differences between H3N2 and H1N1 influenza 2012 and lower respiratory tract infection found using a statistical classification approach.

Authors:  Dimitris Petridis; Paul Zarogoulidis; Anastasios Kallianos; Ioannis Kioumis; Georgia Trakada; Dionysios Spyratos; Antonis Papaiwannou; Konstantinos Porpodis; Haidong Huang; Aggeliki Rapti; Wolfgang Hohenforst-Schmidt; Konstantinos Zarogoulidis
Journal:  Ther Clin Risk Manag       Date:  2014-02-07       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.